Health
Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma – News-Medical.Net
Chimeric Antigen Receptor T-cell therapy–CAR T–has revolutionized leukemia treatment. Unfortunately, the therapy has not been effective for treating solid tumors…
Chimeric Antigen Receptor T-cell therapy–CAR T–has revolutionized leukemia treatment. Unfortunately, the therapy has not been effective for treating solid tumors including childhood cancers such as neuroblastoma. Preclinical studies using certain CAR T against neuroblastoma revealed toxic effects.
Now, a group of scientists at Children’s Hospital Los Angeles have developed a modified version of CAR T that shows promise in targeting neuroblastoma, spares healthy brain tissue and more effectively…
-
Business19 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News19 hours agoYoung voices shape Sunshine Coast’s future
-
General23 hours agoUS stocks sink further as Donald Trump urges Americans to be ‘courageous and patient’
-
General23 hours agoDonald Trump threatens China with additional 50 per cent tariff as trade war threatens to escalate